Self-harm Behaviour Among the Most At-risk Adolescents

Recruiting Observational Study
Self-harm Personality Disorder, Borderline Epigenetic Disorder Non-Suicidal Self Injury Change; Mental Difference, Individual
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
13 – 18
Sex
Any
Study type
Observational
Participants needed
400 (estimated)
Sponsor
University of Ljubljana, Faculty of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In the proposed study, three objectives will be pursued: 1. To develop a method to identify more effectively the acute and long-term risk of adolescents with the most threatening self-harm behaviours. 2. To identify the factors that influence the risk of self-harm behaviours and the success of treatment/treatment of these behaviours in the most at-risk adolescents (changes in these factors). 3. D…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
CLINICAL GROUP: Inclusion Criteria: * Suicidality * Self-harming with no intention to die Exclusion Criteria: * Confirmed acute psychotic disorder * Intellectual disability * Severe physical illness (e.g. cardiovascular or renal disease) * Disease of the central nervous system (e.g. encephalitis…
Contacts

Maja Drobnič Radobuljac

015874840

maja.radobuljac@psih-klinika.si

CONTACT

Maja Drobnič Radobuljac

maja.radobuljac@psih-klinika.si

CONTACT